Tags : Health and Social Care

AI/ML

Oxford Drug Design secures £2.2 million Series A investment from

Oxford Drug Design wins UK-China AMR grant and boosts funding with investment from the Angel CoFund  Oxford University biotech spin-out receives over £2 million to take its drug discovery programme to the next level Oxford, 5th November 2019 – Oxford Drug Design Limited (ODD), a biotechnology company with a proprietary computational and machine learning platform, has raised a […]Read More